Seeing Is Believing
Currently out of the existing stock ratings of Roger Song, 37 are a BUY (86.05%), 6 are a HOLD (13.95%).
Analyst Roger Song, currently employed at JEFFERIES, carries an average stock price target met ratio of 25.46% that have a potential upside of 32.9% achieved within 117 days.
Roger Song’s has documented 87 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TRML, Tourmaline Bio at 09-Sep-2025.
Analyst best performing recommendations are on REPL (REPLIMUNE GROUP).
The best stock recommendation documented was for REPL (REPLIMUNE GROUP) at 7/22/2025. The price target of $6 was fulfilled within 8 days with a profit of $3.19 (113.52%) receiving and performance score of 141.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1
$0.7 (233.33%)
$4
2 years 1 months 26 days ago
(14-Aug-2023)
0/6 (0%)
$0.49 (96.08%)
Hold
$1
$0.7 (233.33%)
$4
2 years 1 months 29 days ago
(11-Aug-2023)
0/6 (0%)
$0.44 (78.57%)
Buy
$25
2 years 1 months 29 days ago
(11-Aug-2023)
0/4 (0%)
$18.48 (1258.95%)
Buy
$20
2 years 6 months 9 days ago
(31-Mar-2023)
1/3 (33.33%)
$14.51 (264.30%)
220
Buy
$27
3 years 4 months 21 days ago
(19-May-2022)
0/1 (0%)
$18.23 (207.87%)
Which stock is Roger Song is most bullish on?
Which stock is Roger Song is most reserved on?
What Year was the first public recommendation made by Roger Song?